Serum Institute of India: COVOVAX (Novavax formulation)

Vaccine Type: Protein Subunit

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 0 Trials

There are no trials for this phase.

Phase 2: 1 Trial

Phase 3: 1 Trial

Approvals

Caribbean Regulatory System Emergency Use Recommendation

WHO Emergency Use Listing

5 Countries

This vaccine is the same formulation as the Novavax vaccine (NVX-CoV2373)

Registered Trials